top of page

Amnis Therapeutics

Endovascular Technologies for Emergency Situations

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Company Founded Year
Company Number of Employees
Amnis Therapeutics
Consumer Electronics

Amnis Therapeutics is a biomedical engineering company specializing in developing, manufacturing, and marketing lifesaving endovascular technologies for emergency situations. Its mission is to provide the medical community with innovative, high-performance devices that offer a reliable, proven solution for numerous endovascular indications.

The company’s AneugraftDx is a pericardium covered coronary stent for emergency vessel reconstruction in cases of acute rupture or dissection of a coronary artery, coronary aneurysm, or saphenous vein graft reperfusion.

The AneugraftNx is a neurovascular pericardium covered stent designed specifically for intracranial indications such as aneurysms, ruptures, and cavernous carotid fistulas (CCFs). The innovative, biologically covered stents provide immediate blood vessel reconstruction in a one-step procedure.

In addition to its covered stent technology, Amnis Therapeutics is expanding its product development to include other unique solutions for emergency intra-arterial interventions. The most recent of these products is the Golden Retriever, a mechanical neurothrombectomy device for the emergency treatment of acute ischemic stroke.

bottom of page